Efficacy and Safety of Ticagrelor versus Clopidogrel in Dialysis Patients with Coronary Syndromes: A Systematic Review and Meta-Analysis

(1) Background: The optimal antiplatelet therapy for end-stage kidney disease (ESKD) patients on chronic dialysis presenting with acute or chronic coronary syndromes (ACS or CCS) remains uncertain. This meta-analysis aimed to compare the efficacy and safety endpoints of ticagrelor and clopidogrel in...

Descripción completa

Detalles Bibliográficos
Autores principales: Burlacu, Alexandru, Floria, Mariana, Brinza, Crischentian, Covic, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419464/
https://www.ncbi.nlm.nih.gov/pubmed/37568413
http://dx.doi.org/10.3390/jcm12155011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419464/
https://www.ncbi.nlm.nih.gov/pubmed/37568413
http://dx.doi.org/10.3390/jcm12155011

Ejemplares similares